Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non ‐alcoholic fatty liver disease

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - September 4, 2018 Category: Endocrinology Authors: Masanori Shimizu , Kunihiro Suzuki , Kanako Kato , Teruo Jojima , Toshie Iijima , Toshimitsu Murohisa , Makoto Iijima , Hidehiro Takekawa , Isao Usui , Hideyuki Hiraishi , Yoshimasa Aso Source Type: research